Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age.
Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age. Biol Blood Marrow Transplant. 2010 Jun; 16(6):792-800.
-
Joseph Harry Antin, M.D.
-
Jerome Ritz, M.D.
-
Philippe Armand, M.D.,Ph.D.
-
John Koreth, M.B.,B.S.
-
Vincent T. Ho, M.D.
-
Corey Stephen Cutler, M.D.
-
Haesook Teresa Kim, Ph.D.
-
Robert Jon Soiffer, M.D.